Author

Pier P Lindenbergh

Leiden UniversityORCID 0009-0003-4816-2455Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Amanda C FoksiD· 1 shared B. A. J. A. van de SluisiD· 1 shared Bram SluetteriD· 1 shared Eveline A de VliegeriD· 1 shared Ewa B. Snaar-JagalskaiD· 1 shared Gabriel Forn‐CuníiD· 1 shared Gangyin ZhaoiD· 1 shared Ilze BotiD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPathology

Amanda C FoksORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

PathologybioRxivPreprintNov 10, 2026

CD8+ T-cells protect against experimental atherosclerosis through antigen specific interactions in the plaque

Eveline A de Vlieger, Maaike J.M. de Jong, Jeroen Molenaar…·Bram Sluetter

This study shows that antigen-specific CD8+ T cells reduce atherosclerotic plaque burden and stabilize plaques by decreasing secondary necrosis and CD47 expression on foam cells.

DOI 10.64898/2026.11.09.765252

mouseexperimental assay

𝕏 PostBluesky

Cancer BiologyCancer LettersPeer-reviewedFeb 7, 2024

Simultaneous targeting of AMPK and mTOR is a novel therapeutic strategy against prostate cancer

Gangyin Zhao, Gabriel Forn‐Cuní, Marvin Scheers…·Ewa B. Snaar-Jagalska

This study shows that targeting both AMPK and mTOR can inhibit prostate cancer metastasis by blocking the metabolic switch required for tumor growth in new environments.

24 citations

humanexperimental assay

𝕏 PostBluesky